Ju-Hwa Kim

535 citations
14 papers · 448 indexed · h-index 13
Topics
Drug Transport and Resistance Mechanisms (5 papers)Cancer therapeutics and mechanisms (4 papers)Cancer Cells and Metastasis (3 papers)
Partner nations
South Korea

In The Last Decade

Ju-Hwa Kim

14 papers receiving 446 citations

Peers

Ju-Hwa Kim
Comparison fields: 5 of 62
  • Molecular Biology 295
  • Oncology 239
  • Pathology and Forensic Medicine 79
  • Cancer Research 53
  • Epidemiology 32
Replace Shih‐Chieh Chiang with:
Shih‐Chieh Chiang United Kingdom
Junmei Hou China
Ruth Eichner Germany
Chunwan Lu United States
Yongping Cui China
Guillaume Jacquemin France
William Guerrant United States
Estelle G. McLean United Kingdom
Sharon Tran Australia
Izabela Szulc-Kiełbik Poland
Ju-Hwa Kim relative to Shih‐Chieh Chiang United Kingdom Shih‐Chieh Chiang's profile →
Citations per field
00.5×4.6×
Shih‐Chieh Chiang · 1×
Citations per year

Countries citing papers authored by Ju-Hwa Kim

Since Specialization
Citations

This map shows the geographic impact of Ju-Hwa Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju-Hwa Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju-Hwa Kim more than expected).

Fields of papers citing papers by Ju-Hwa Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju-Hwa Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju-Hwa Kim. The network helps show where Ju-Hwa Kim may publish in the future.

Co-authorship network of co-authors of Ju-Hwa Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Ju-Hwa Kim. A scholar is included among the top collaborators of Ju-Hwa Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju-Hwa Kim. Ju-Hwa Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 35
2 24
3
Anti-malarial Drugs Primaquine and Chloroquine Have Different Sensitization Effects with Anti-mitotic Drugs in Resistant Cancer Cells.
33
4
Co-treatment of Salinomycin Sensitizes AZD5363-treated Cancer Cells Through Increased Apoptosis.
10
5 19
6 16
7 20
8 32
9 68
10 14
11 63
12 26
13 27
14 61

About Ju-Hwa Kim

Ju-Hwa Kim is a scholar working on Toxicology, Oncology and Virology, having authored 14 papers that have together received 448 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Cancer therapeutics and mechanisms (4 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Oncology (239 citations), Toxicology (24 citations) and Pathology and Forensic Medicine (79 citations). Ju-Hwa Kim has collaborated with scholars based in South Korea. Frequent co-authors include Sungpil Yoon, Ae‐Ran Choi, Han Sung Kang, Jungsil Ro, Hyung Sik Kim, Kyungsil Yoon, Sunshin Kim, Yong Kee Kim, Tae Hyung Kim and Young‐Su Yi. Their work appears in journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026